These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 28525289)

  • 1. High-Throughput Phenotyping of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Neurons Using Electric Field Stimulation and High-Speed Fluorescence Imaging.
    Daily NJ; Du ZW; Wakatsuki T
    Assay Drug Dev Technol; 2017; 15(4):178-188. PubMed ID: 28525289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Changes in Morphology and Function of Human Induced Pluripotent Stem Cell Derived Cardiomyocytes (HiPSC-CMs) Cultured on an Aligned-Nanofiber Cardiac Patch.
    Khan M; Xu Y; Hua S; Johnson J; Belevych A; Janssen PM; Gyorke S; Guan J; Angelos MG
    PLoS One; 2015; 10(5):e0126338. PubMed ID: 25993466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deep phenotyping of human induced pluripotent stem cell-derived atrial and ventricular cardiomyocytes.
    Cyganek L; Tiburcy M; Sekeres K; Gerstenberg K; Bohnenberger H; Lenz C; Henze S; Stauske M; Salinas G; Zimmermann WH; Hasenfuss G; Guan K
    JCI Insight; 2018 Jun; 3(12):. PubMed ID: 29925689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimodal on-axis platform for all-optical electrophysiology with near-infrared probes in human stem-cell-derived cardiomyocytes.
    Klimas A; Ortiz G; Boggess SC; Miller EW; Entcheva E
    Prog Biophys Mol Biol; 2020 Aug; 154():62-70. PubMed ID: 30850184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual optical recordings for action potentials and calcium handling in induced pluripotent stem cell models of cardiac arrhythmias using genetically encoded fluorescent indicators.
    Song L; Awari DW; Han EY; Uche-Anya E; Park SH; Yabe YA; Chung WK; Yazawa M
    Stem Cells Transl Med; 2015 May; 4(5):468-75. PubMed ID: 25769651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NanoMEA: A Tool for High-Throughput, Electrophysiological Phenotyping of Patterned Excitable Cells.
    Smith AST; Choi E; Gray K; Macadangdang J; Ahn EH; Clark EC; Laflamme MA; Wu JC; Murry CE; Tung L; Kim DH
    Nano Lett; 2020 Mar; 20(3):1561-1570. PubMed ID: 31845810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of calcium-sensitive dyes on the beating properties and pharmacological responses of human iPS-derived cardiomyocytes using the calcium transient assay.
    Kopljar I; Hermans AN; Teisman A; Gallacher DJ; Lu HR
    J Pharmacol Toxicol Methods; 2018; 91():80-86. PubMed ID: 29421525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-induced functional cardiotoxicity screening in stem cell-derived human and mouse cardiomyocytes: effects of reference compounds.
    Himmel HM
    J Pharmacol Toxicol Methods; 2013; 68(1):97-111. PubMed ID: 23702537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of cardiomyocyte contraction in human-induced pluripotent stem cell-derived cardiomyocytes.
    Pointon A; Harmer AR; Dale IL; Abi-Gerges N; Bowes J; Pollard C; Garside H
    Toxicol Sci; 2015 Apr; 144(2):227-37. PubMed ID: 25538221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-Throughput and Cost-Effective Characterization of Induced Pluripotent Stem Cells.
    D'Antonio M; Woodruff G; Nathanson JL; D'Antonio-Chronowska A; Arias A; Matsui H; Williams R; Herrera C; Reyna SM; Yeo GW; Goldstein LSB; Panopoulos AD; Frazer KA
    Stem Cell Reports; 2017 Apr; 8(4):1101-1111. PubMed ID: 28410643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-Specific and Genome-Edited Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Brugada Syndrome.
    Liang P; Sallam K; Wu H; Li Y; Itzhaki I; Garg P; Zhang Y; Vermglinchan V; Lan F; Gu M; Gong T; Zhuge Y; He C; Ebert AD; Sanchez-Freire V; Churko J; Hu S; Sharma A; Lam CK; Scheinman MM; Bers DM; Wu JC
    J Am Coll Cardiol; 2016 Nov; 68(19):2086-2096. PubMed ID: 27810048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient generation of functional cardiomyocytes from human umbilical cord-derived virus-free induced pluripotent stem cells.
    Wu KH; Wang SY; Xiao QR; Yang Y; Huang NP; Mo XM; Sun J
    Cell Tissue Res; 2018 Nov; 374(2):275-283. PubMed ID: 29961217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe DCM phenotype of patient harboring RBM20 mutation S635A can be modeled by patient-specific induced pluripotent stem cell-derived cardiomyocytes.
    Streckfuss-Bömeke K; Tiburcy M; Fomin A; Luo X; Li W; Fischer C; Özcelik C; Perrot A; Sossalla S; Haas J; Vidal RO; Rebs S; Khadjeh S; Meder B; Bonn S; Linke WA; Zimmermann WH; Hasenfuss G; Guan K
    J Mol Cell Cardiol; 2017 Dec; 113():9-21. PubMed ID: 28941705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Non-Coding RNAs in Exosomes and Functional Efficacy of Human Embryonic Stem Cell- versus Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Lee WH; Chen WY; Shao NY; Xiao D; Qin X; Baker N; Bae HR; Wei TT; Wang Y; Shukla P; Wu H; Kodo K; Ong SG; Wu JC
    Stem Cells; 2017 Oct; 35(10):2138-2149. PubMed ID: 28710827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Friedreich's ataxia induced pluripotent stem cell-derived cardiomyocytes display electrophysiological abnormalities and calcium handling deficiency.
    Crombie DE; Curl CL; Raaijmakers AJ; Sivakumaran P; Kulkarni T; Wong RC; Minami I; Evans-Galea MV; Lim SY; Delbridge L; Corben LA; Dottori M; Nakatsuji N; Trounce IA; Hewitt AW; Delatycki MB; Pera MF; Pébay A
    Aging (Albany NY); 2017 May; 9(5):1440-1452. PubMed ID: 28562313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural Changes in N-Glycans on Induced Pluripotent Stem Cells Differentiating Toward Cardiomyocytes.
    Kawamura T; Miyagawa S; Fukushima S; Kashiyama N; Kawamura A; Ito E; Saito A; Maeda A; Eguchi H; Toda K; Miyagawa S; Okuyama H; Sawa Y
    Stem Cells Transl Med; 2015 Nov; 4(11):1258-64. PubMed ID: 26378261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic Assays for Characterizing Compound Effects on Induced Pluripotent Stem Cell-Derived Cardiac Spheroids.
    Sirenko O; Hancock MK; Crittenden C; Hammer M; Keating S; Carlson CB; Chandy G
    Assay Drug Dev Technol; 2017; 15(6):280-296. PubMed ID: 28837356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Profiling of Human Induced Pluripotent Stem Cell-Derived Cells and their Application for Drug Safety Study.
    Matsui T; Miyamoto N; Saito F; Shinozawa T
    Curr Pharm Biotechnol; 2020; 21(9):807-828. PubMed ID: 32321398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation and characterization of rhesus monkey atrial and ventricular cardiomyocytes from induced pluripotent stem cells.
    Zhang X; Cao H; Bai S; Huo W; Ma Y
    Stem Cell Res; 2017 Apr; 20():21-29. PubMed ID: 28249229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Characterization of a Scaffold-Free 3D Spheroid Model of Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes.
    Beauchamp P; Moritz W; Kelm JM; Ullrich ND; Agarkova I; Anson BD; Suter TM; Zuppinger C
    Tissue Eng Part C Methods; 2015 Aug; 21(8):852-61. PubMed ID: 25654582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.